Conditional Mutagenesis to Study c-Myb Function

研究 c-Myb 功能的条件诱变

基本信息

  • 批准号:
    7891202
  • 负责人:
  • 金额:
    $ 32.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-01-05 至 2012-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): It is clear that the Myb protooncogene plays a crucial role during hematopoiesis. In each hematopoietic lineage, c-Myb is abundantly expressed at the immature stages of differentiation and is turned off at a relatively late time during the differentiation process. However, virtually nothing is known about what role c- Myb plays during hematopoietic maturation, how that role is mediated or what signaling pathways regulate c- Myb expression. Mice that are homozygous null at the Myb locus die at day fifteen during embryogenesis from a severe anemia. This finding graphically demonstrated the significance of c-Myb during hematopoiesis but has precluded study of c-Myb activity at the later stages of differentiation. The lack of a tractable genetic system that will allow mutation of Myb during the later stages of hematopoietic maturation has been a major impediment to understanding the role of c-Myb during hematopoiesis. During T cell development in the thymus, CD4 and CD8 double negative (DM) and double positive (DP) thymocytes contain abundant amounts of c-Myb while CD4+ and CD8+ single positive (SP) cells contain only 10 to 20% as much c-Myb. In the periphery, c-Myb is expressed at only low levels in resting T cells, but expression increases in proliferating T cells in late G1/early SD phase of the cell cycle. To begin to understand the role played by c- Myb during T cell development we have produced mice that carry a Myb allele targeted with loxP sites for deletion by the Cre recombinase. By breeding these mice to available mouse strains that direct Cre expression to different stages of T cell development in the thymus we have defined critical points during T cell development where c-Myb is required: transition from the DN to the DP stage of development, for the survival of pre-selection DP cells and the differentiation of CD4 SP thymocytes. More recently we have identified roles for c-Myb in maintaining T cell homeostasis and mediating T cell helper function. The goals of this proposal are to understand the basis for c-Myb function during the DN stage of T cell development, in peripheral T homeostasis and helper T cell function.
描述(由申请人提供):很明显,Myb原癌基因在造血过程中起着至关重要的作用。在每个造血谱系中,c-Myb在分化的不成熟阶段大量表达,并且在分化过程中的相对较晚的时间关闭。然而,事实上对c-Myb在造血成熟过程中起什么作用,这种作用是如何介导的或什么信号通路调节c-Myb表达还一无所知。在Myb基因座处纯合无效的小鼠在胚胎发生期间的第15天死于严重贫血。这一发现生动地证明了c-Myb在造血过程中的重要性,但排除了在分化后期c-Myb活性的研究。缺乏一个易于处理的遗传系统,将允许突变的Myb在造血成熟的后期阶段一直是一个主要的障碍,以了解c-Myb在造血过程中的作用。在胸腺中T细胞发育期间,CD 4和CD 8双阴性(DM)和双阳性(DP)胸腺细胞含有大量的c-Myb,而CD 4+和CD 8+单阳性(SP)细胞仅含有10 - 20%的c-Myb。在外周,c-Myb在静息T细胞中仅以低水平表达,但在细胞周期的G1晚期/早期SD期的增殖T细胞中表达增加。为了开始理解c-Myb在T细胞发育过程中所起的作用,我们生产了携带Myb等位基因的小鼠,该等位基因被Cre重组酶用loxP位点靶向缺失.通过将这些小鼠与可获得的小鼠品系(其将Cre表达引导至胸腺中T细胞发育的不同阶段)进行育种,我们已经定义了T细胞发育期间需要c-Myb的关键点:从DN向DP发育阶段的过渡,用于预选DP细胞的存活和CD 4 SP胸腺细胞的分化。最近,我们已经确定了c-Myb在维持T细胞稳态和介导T细胞辅助功能中的作用。本研究的目的是了解c-Myb在T细胞发育的DN阶段、外周T细胞稳态和辅助性T细胞功能中的作用基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Timothy P. Bender其他文献

Differentiation of mouse erythroleukemia cells is blocked by late up-regulation of a c-myb transgene
c-myb 转基因的晚期上调阻碍了小鼠红白血病细胞的分化
  • DOI:
    10.1128/mcb.10.2.705-710.1990
  • 发表时间:
    1990
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Diana McCLINTON;Jeannine Stafford;Leslie;Brents;Timothy P. Bender;W. Michael;'. Kuehl
  • 通讯作者:
    '. Kuehl
Expression of a transfected human c-myconcogene inhibits differentiation of a mouse erythroleukaemia cell line
转染的人 c-myc 癌基因的表达抑制小鼠红白血病细胞系的分化
  • DOI:
    10.1038/322748a0
  • 发表时间:
    1986-08-21
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Ethan Dmitrovsky;W. Michael Kuehl;Gregory F. Hollis;Ilan R. Kirsch;Timothy P. Bender;Shoshana Segal
  • 通讯作者:
    Shoshana Segal
Considerations for the physical vapor deposition of high molar mass organic compounds
  • DOI:
    10.1016/j.vacuum.2014.05.023
  • 发表时间:
    2014-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jeffrey S. Castrucci;Jeremy D. Dang;Brett A. Kamino;Andrew Campbell;David Pitts;Zheng-Hong Lu;Timothy P. Bender
  • 通讯作者:
    Timothy P. Bender
Redox behaviour of boron subphthalocyanine carbon nanotube composites
  • DOI:
    10.1016/j.nxmate.2024.100163
  • 发表时间:
    2024-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Raunaq Bagchi;Erika Remigio;Dian Yu;Nina F. Farac;Averey Kudlow;Jane Howe;Timothy P. Bender;Keryn Lian
  • 通讯作者:
    Keryn Lian

Timothy P. Bender的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Timothy P. Bender', 18)}}的其他基金

Signaling and Transcriptional Control of T Follicular Helper Cells and RBC Alloimmunization
滤泡辅助 T 细胞和红细胞同种免疫的信号传导和转录控制
  • 批准号:
    9753378
  • 财政年份:
    2018
  • 资助金额:
    $ 32.08万
  • 项目类别:
c-Myb in CD4 T cells is crucial for recall antibody responses
CD4 T 细胞中的 c-Myb 对于记忆抗体反应至关重要
  • 批准号:
    8820986
  • 财政年份:
    2014
  • 资助金额:
    $ 32.08万
  • 项目类别:
c-Myb controls survival, proliferation and differentiation during B-lymphopoiesis
c-Myb 控制 B 淋巴细胞生成过程中的存活、增殖和分化
  • 批准号:
    8478146
  • 财政年份:
    2011
  • 资助金额:
    $ 32.08万
  • 项目类别:
c-Myb fusion proteins in Adenoid Cystic Carcinoma
腺样囊性癌中的 c-Myb 融合蛋白
  • 批准号:
    8303226
  • 财政年份:
    2011
  • 资助金额:
    $ 32.08万
  • 项目类别:
c-Myb controls survival, proliferation and differentiation during B-lymphopoiesis
c-Myb 控制 B 淋巴细胞生成过程中的存活、增殖和分化
  • 批准号:
    8665994
  • 财政年份:
    2011
  • 资助金额:
    $ 32.08万
  • 项目类别:
c-Myb controls survival, proliferation and differentiation during B-lymphopoiesis
c-Myb 控制 B 淋巴细胞生成过程中的存活、增殖和分化
  • 批准号:
    8162936
  • 财政年份:
    2011
  • 资助金额:
    $ 32.08万
  • 项目类别:
ImageSteamX
图像SteamX
  • 批准号:
    8052019
  • 财政年份:
    2011
  • 资助金额:
    $ 32.08万
  • 项目类别:
c-Myb controls survival, proliferation and differentiation during B-lymphopoiesis
c-Myb 控制 B 淋巴细胞生成过程中的存活、增殖和分化
  • 批准号:
    8325520
  • 财政年份:
    2011
  • 资助金额:
    $ 32.08万
  • 项目类别:
c-Myb fusion proteins in Adenoid Cystic Carcinoma
腺样囊性癌中的 c-Myb 融合蛋白
  • 批准号:
    8174241
  • 财政年份:
    2011
  • 资助金额:
    $ 32.08万
  • 项目类别:
Becton Dickinson LSR II
贝克顿·迪金森 LSR II
  • 批准号:
    7594950
  • 财政年份:
    2009
  • 资助金额:
    $ 32.08万
  • 项目类别:

相似国自然基金

基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
  • 批准号:
    82302715
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
  • 批准号:
    31200592
  • 批准年份:
    2012
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
  • 批准号:
    24K10442
  • 财政年份:
    2024
  • 资助金额:
    $ 32.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
  • 批准号:
    23K15297
  • 财政年份:
    2023
  • 资助金额:
    $ 32.08万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Fanconi anemia経路に着目したiPS細胞における高レベル複製ストレスの原因解明
阐明 iPS 细胞中高水平复制应激的原因,重点关注范可尼贫血途径
  • 批准号:
    23K14452
  • 财政年份:
    2023
  • 资助金额:
    $ 32.08万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Analysis of the mechanism of hemolytic anemia in canine babesiosis and development of novel therapeutic measures
犬巴贝斯虫病溶血性贫血机制分析及新治疗措施开发
  • 批准号:
    23KJ0074
  • 财政年份:
    2023
  • 资助金额:
    $ 32.08万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Mobile phone-based screening for anemia in young children in western Kenya
基于手机的肯尼亚西部幼儿贫血筛查
  • 批准号:
    10752968
  • 财政年份:
    2023
  • 资助金额:
    $ 32.08万
  • 项目类别:
Brain blood flow, oxygenation, and cognition in adult onset iron deficiency anemia
成人缺铁性贫血的脑血流量、氧合和认知
  • 批准号:
    10735765
  • 财政年份:
    2023
  • 资助金额:
    $ 32.08万
  • 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
  • 批准号:
    10735366
  • 财政年份:
    2023
  • 资助金额:
    $ 32.08万
  • 项目类别:
Accuracy and Feasibility of Non-Invasive Anemia Screening Assistant (ASIST) Device in Resource-Limited Settings
资源有限环境中非侵入性贫血筛查辅助 (ASIST) 设备的准确性和可行性
  • 批准号:
    10575222
  • 财政年份:
    2023
  • 资助金额:
    $ 32.08万
  • 项目类别:
Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury
新生儿贫血中的肝肠轴及其在红细胞输注相关肠道损伤中的作用
  • 批准号:
    10583807
  • 财政年份:
    2023
  • 资助金额:
    $ 32.08万
  • 项目类别:
A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
  • 批准号:
    10564553
  • 财政年份:
    2023
  • 资助金额:
    $ 32.08万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了